London School of Hygiene and Tropical Medicine, London, United Kingdom.
Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
PLoS One. 2018 Oct 17;13(10):e0204584. doi: 10.1371/journal.pone.0204584. eCollection 2018.
Projections of fertility of HIV positive women as ART scales up are needed to plan prevention of mother-to-child transmission (PMTCT) services. We describe differences in exposure to pregnancy between HIV positive and HIV negative women by age, region and national ART coverage to evaluate the extent to which behavioural differences explain lower fertility among HIV positive women and assess whether exposure to pregnancy has changed with antiretroviral treatment (ART) scale-up.
We analysed 46 nationally representative household surveys in sub-Saharan Africa conducted between 2003 and 2015 to estimate risk of exposure to recent sex and pregnancy of HIV positive and HIV negative women by age using a log binomial model. We tested for regional and urban/rural differences and associations with national ART coverage. We estimated an adjusted fertility rate ratio of HIV positive to HIV negative women adjusting for differences in exposure to pregnancy.
Exposure to pregnancy differs significantly between HIV positive and negative women by age, modified by region. Younger HIV positive women have a higher exposure to pregnancy than HIV negative women and the opposite is true at older ages. The switch occurs at 25-29 for rural women and 30-34 for urban women. There was no evidence that exposure to pregnancy of HIV positive women have changed as national ART coverage increased. The inferred rate of fecundity of HIV positive women when adjusted for differences in exposure to pregnancy were lower than unadjusted fertility rate ratios in women aged 20-29 and 20-24 in urban and rural areas respectively varying between 0.6 and 0.9 over regions.
The direct effects of HIV on fertility are broadly similar across ages, while the dramatic age gradient that has frequently been observed is largely attributable to variation in relative sexual exposure by age.
随着抗逆转录病毒疗法(ART)的推广,需要预测 HIV 阳性妇女的生育能力,以便规划母婴传播预防(PMTCT)服务。我们通过年龄、地区和国家 ART 覆盖率来描述 HIV 阳性和 HIV 阴性妇女的妊娠暴露差异,以评估行为差异在多大程度上导致 HIV 阳性妇女生育率较低,并评估抗逆转录病毒治疗(ART)推广是否改变了妊娠暴露。
我们分析了 2003 年至 2015 年间在撒哈拉以南非洲进行的 46 项具有全国代表性的家庭调查,使用对数二项式模型按年龄估计 HIV 阳性和 HIV 阴性妇女最近发生性行为和妊娠的风险。我们检验了地区和城乡差异以及与国家 ART 覆盖率的关联。我们通过调整妊娠暴露差异,估计了 HIV 阳性与 HIV 阴性妇女的调整生育比率。
年龄、地区修饰后,HIV 阳性和阴性妇女的妊娠暴露存在显著差异。年轻的 HIV 阳性妇女妊娠暴露率高于 HIV 阴性妇女,而年龄较大的妇女则相反。这种转变在农村地区发生在 25-29 岁,在城市地区发生在 30-34 岁。随着国家 ART 覆盖率的增加,HIV 阳性妇女妊娠暴露没有证据表明发生了变化。当调整妊娠暴露差异时,HIV 阳性妇女的生育率低于未经调整的生育比率,在城乡地区 20-29 岁和 20-24 岁年龄组分别为 0.6 至 0.9 不等,不同地区有所差异。
HIV 对生育能力的直接影响在各个年龄段基本相似,而经常观察到的显著年龄梯度主要归因于年龄相关的相对性暴露的变化。